SAVIENT PHARMACEUTICALS INC - FORM 10-Q - EX-32.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 906 - August 8, 2011

Attached files

file filename
10-Q - FORM 10-Q - SAVIENT PHARMACEUTICALS INCd10q.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - SAVIENT PHARMACEUTICALS INCdex312.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - SAVIENT PHARMACEUTICALS INCdex311.htm
EX-10.1 - EMPLOYMENT AGREEMENT - SAVIENT PHARMACEUTICALS INCdex101.htm
EX-32.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 906 - SAVIENT PHARMACEUTICALS INCdex321.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Savient Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David G. Gionco, Group Vice President, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

By:   / S / DAVID G. GIONCO
  Group Vice President, Chief Financial Officer & Treasurer

August 8, 2011

SAVIENT PHARMACEUTICALS INC Reports